Literature DB >> 9328826

Detection and cloning of epidermal zinc-alpha 2-glycoprotein cDNA and expression in normal human skin and in tumors.

G Lei1, I Arany, P Selvanayagam, S Rajaraman, S Ram, H Brysk, S K Tyring, M M Brysk.   

Abstract

Zinc-alpha 2-glycoprotein (Zn alpha 2gp) is almost ubiquitous in body fluids, and its antibody labels the corresponding secretory epithelia. We have found that Zn alpha 2gp is also expressed in human epidermis. We cloned the Zn alpha 2gp cDNA by screening our cDNA library, derived from epidermal keratinocytes, with a probe for prostate Zn alpha 2gp. It had complete nucleic acid sequence homology with that from prostate, including the signal peptide. Just as Zn alpha 2gp expression is higher in more differentiated breast tumors, so in skin tumors the highest mRNA levels occurred in the normal controls, the lowest in basal cell carcinomas (the least differentiated epidermal tumor type), and intermediate levels in squamous cell carcinomas and Merkel cell carcinomas. A similar increase in Zn alpha 2gp gene expression with differentiation was observed when epidermal keratinocytes were cultured in media that varied in cellular maturation potential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328826

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis.

Authors:  Yan Huang; Lin-Zi Li; Chris Zhi-Yi Zhang; Chun Yi; Li-Li Liu; Xuan Zhou; Guo-Bing Xie; Mu-Yan Cai; Yan Li; Jing-Ping Yun
Journal:  J Transl Med       Date:  2012-05-24       Impact factor: 5.531

2.  The Newest Hypothesis about Vitiligo: Most of the Suggested Pathogeneses of Vitiligo Can Be Attributed to Lack of One Factor, Zinc-α2-Glycoprotein.

Authors:  Nooshin Bagherani
Journal:  ISRN Dermatol       Date:  2012-06-19

3.  Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China.

Authors:  Hong Tang; Yufeng Wu; Yanru Qin; Haiying Wang; Lili Wang; Xinyuan Guan; Suxia Luo; Qiming Wang
Journal:  Onco Targets Ther       Date:  2016-12-20       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.